GGrantIndex
← Leaderboards

George W Jackson

Biotex, Inc.

Google Scholar ↗PubMed ↗ORCID ↗
$8,214,972
Attributed
$8,214,972
Total exposure
14
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2007–25
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,064,972 · 13
CDC$150,000 · 1

By mechanism

R44$6,542,889 · 5
R43$1,252,083 · 7
N01$300,000 · 1
R41$120,000 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Technology”

Research focus

TechnologyBaseAptamerSmall Business Innovation Research GrantSpecificitySamplingInstrumentMeasurementDesignDevicesLaboratoriesDiagnosticComputer SoftwareMethodologyOpticsPharmaceutical PreparationsProtocols DocumentationUniversitiesEngineeringLabelDetectionUnited StatesBloodPrototype

Grant awards (23)

Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection$746,175
R44 · FY2025 · EB · contact PI
Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection$751,525
R44 · FY2024 · EB · contact PI
APTASENSORS FOR MEASURING LONG TERM ADHERENCE TO TENOFOVIR-BASED AND LONG ACTING HIV TREATMENT REGIMENS$300,000
N01 · FY2024 · DA · contact PI
Aptamer engineering of lentiviral vectors for cardiac gene therapies$289,665
R43 · FY2023 · HL · contact PI
Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection$266,072
R44 · FY2023 · EB · contact PI
Neonatal Opioid Screening Using Aptamers and Compensated Interferometry$559,883
R44 · FY2021 · DA · contact PI
Neonatal Opioid Screening Using Aptamers and Compensated Interferometry$582,503
R44 · FY2020 · DA · contact PI
Rapid, Quantitative Point-of-Care Measurement of Tuberculosis Treatment Adherence$221,014
R43 · FY2020 · AI · contact PI
Neonatal Opioid Screening Using Aptamers and Compensated Interferometry$99,997
R44 · FY2020 · DA · contact PI
Neonatal Opioid Screening Using Aptamers and Compensated Interferometry$215,306
R44 · FY2019 · DA · contact PI
Portable nanofluidic aptamer-SERS instrument for measurement of chemical exposure$704,977
R44 · FY2017 · ES · contact PI
SBIR, PA16-302, Point-of-care aptamer-based surface enhanced Raman scattering (aptamer-SERS) detection of malaria metabolites in urine and saliva$150,000
R43 · FY2017 · GH · contact PI
Portable nanofluidic aptamer-SERS instrument for measurement of chemical exposure$714,230
R44 · FY2016 · ES · contact PI
Platform for Massively Parallel Selection of Aptamer Ligands$433,652
R44 · FY2012 · GM · contact PI
Portable nanofluidic aptamer-SERS instrument for measurement of chemical exposure$248,891
R43 · FY2012 · ES · contact PI
Platform for Massively Parallel Selection of Aptamer Ligands$537,165
R44 · FY2011 · GM · contact PI
Rapid Microbial Identification by MALDI-TOF Mass Spectrometry of Ribosomal RNA$325,816
R44 · FY2010 · AI · contact PI
Rapid Microbial Identification by MALDI-TOF Mass Spectrometry of Ribosomal RNA$208,913
R44 · FY2010 · AI · contact PI
Rapid Microbial Identification by MALDI-TOF Mass Spectrometry of Ribosomal RNA$396,675
R44 · FY2009 · AI · contact PI
Platform for Massively Parallel Selection of Aptamer Ligands$123,624
R43 · FY2009 · GM · contact PI
In vivo Selection of Ribosomal Aptamers for Improved Bioremediation$120,000
R41 · FY2008 · ES · contact PI
Temperature Gradient Hybridizer and Real-time Imager for DNA Microarrays$111,945
R43 · FY2008 · GM · contact PI
Rapid Microbial Identification by MALDI-TOF Mass Spectrometry of Ribosomal RNA$106,944
R43 · FY2007 · AI · contact PI